| XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors MC Michel, A Beck-Sickinger, H Cox, HN Doods, H Herzog, ... Pharmacological reviews 50 (1), 143-150, 1998 | 1072 | 1998 |
| International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors DR Poyner, PM Sexton, I Marshall, DM Smith, R Quirion, W Born, R Muff, ... Pharmacological reviews 54 (2), 233-246, 2002 | 965 | 2002 |
| A proposal for the classification of sigma binding sites R Quirion Trends Pharmacol Sci 13, 85-86, 1992 | 956 | 1992 |
| Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies DS Auld, TJ Kornecook, S Bastianetto, R Quirion Progress in neurobiology 68 (3), 209-245, 2002 | 915 | 2002 |
| Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. J Poirier, MC Delisle, R Quirion, I Aubert, M Farlow, D Lahiri, S Hui, ... Proceedings of the National Academy of Sciences 92 (26), 12260-12264, 1995 | 787 | 1995 |
| “APUD” Cells FAO Mendelsohn, R Quirion, JM Saavedra brain 81, 1575, 1984 | 677 | 1984 |
| Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors D Van Rossum, UK Hanisch, R QUIRION Neuroscience & Biobehavioral Reviews 21 (5), 649-678, 1997 | 633 | 1997 |
| The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloid S Bastianetto, C Ramassamy, S Doré, Y Christen, J Poirier, R Quirion European Journal of Neuroscience 12 (6), 1882-1890, 2000 | 518 | 2000 |
| Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues Y Dumont, JC Martel, A Fournier, S St-Pierre, R Quirion Progress in neurobiology 38 (2), 125-167, 1992 | 491 | 1992 |
| The effects of chronic antidepressant treatment in an animal model of anxiety SR Bodnoff, B Suranyi-Cadotte, DH Aitken, R Quirion, MJ Meaney Psychopharmacology 95, 298-302, 1988 | 447 | 1988 |
| Say NO to Alzheimer’s disease: the putative links between nitric oxide and dementia of the Alzheimer’s type A Law, S Gauthier, R Quirion Brain research reviews 35 (1), 73-96, 2001 | 444 | 2001 |
| Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis P Seeman, D Weinshenker, R Quirion, LK Srivastava, SK Bhardwaj, ... Proceedings of the National Academy of Sciences 102 (9), 3513-3518, 2005 | 439 | 2005 |
| Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. D Barbeau, JJ Liang, Y Robitalille, R Quirion, LK Srivastava Proceedings of the National Academy of Sciences 92 (7), 2785-2789, 1995 | 421 | 1995 |
| Phencyclidine (angel dust)/sigma" opiate" receptor: visualization by tritium-sensitive film. R Quirion, RP Hammer Jr, M Herkenham, CB Pert Proceedings of the National Academy of Sciences 78 (9), 5881-5885, 1981 | 421 | 1981 |
| Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide‐related toxicity in cultured hippocampal neurons S Bastianetto, WH Zheng, R Quirion British journal of pharmacology 131 (4), 711-720, 2000 | 420 | 2000 |
| The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y A Kask, J Harro, S von Hörsten, JP Redrobe, Y Dumont, R Quirion Neuroscience & Biobehavioral Reviews 26 (3), 259-283, 2002 | 415 | 2002 |
| Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases I Aubert, DM Araujo, D Cecyre, Y Robitaille, S Gauthier, R Quirion Journal of neurochemistry 58 (2), 529-541, 1992 | 412 | 1992 |
| Neuroprotective action of resveratrol S Bastianetto, C Ménard, R Quirion Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (6 …, 2015 | 408 | 2015 |
| Psychiatry as a clinical neuroscience discipline TR Insel, R Quirion Jama 294 (17), 2221-2224, 2005 | 404 | 2005 |
| Psychosis pathways converge via D2High dopamine receptors P Seeman, J Schwarz, JF Chen, H Szechtman, M Perreault, GS McKnight, ... Synapse 60 (4), 319-346, 2006 | 396 | 2006 |
